Clearmind Medicine Inc (CMND)
Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder
Zynex Inc (ZYXI)
Zynex Announces Steven Dyson as New CEO
Regencell Bioscience Holdings Ltd (RGC)
Immuneering Corporation (IMRX)
Zai Lab Limited (ZLAB)
Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer
Tyra Biosciences Inc. (TYRA)
Tyra Biosciences Doses First Patient in Phase 2 Study of TYRA-300 in Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)
Athersys Inc. (ATHX)
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
Applied DNA Sciences Inc. (APDN)
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
Amgen Inc (AMGN)
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b (FGFR2b) POSITIVE FIRST-LINE GASTRIC CANCER
Kronos Bio Inc (KRON)
Windtree Therapeutics Inc. (WINT)
Windtree Announces Istaroxime Phase 2 Cardiogenic Shock Study Hits Enrollment Target for Planned Interim Analysis
Regencell Bioscience Holdings Ltd (RGC)
Bone Biologics Corp (BBLGW)
Fortrea Holdings Inc (FTRE)
Shareholders that lost money on Fortrea Holdings Inc.(FTRE) should contact The Gross Law Firm about pending Class Action - FTRE
Jaguar Health Inc. (JAGX)
Proof-of-Concept Results Show Jaguar Healths Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient